tiprankstipranks
Trending News
More News >
Capstone Therapeutics Corp (CAPS)
:CAPS
US Market
Advertisement

Capstone Therapeutics (CAPS) Income Statement

Compare
28 Followers

Capstone Therapeutics Income Statement

Last quarter (Q1 2025), Capstone Therapeutics's total revenue was $7.90M, a decrease of -15.60% from the same quarter last year. In Q1, Capstone Therapeutics's net income was $-2.43M. See Capstone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 44.88M$ 48.35M$ 61.56M$ 66.74M$ 45.45M
Gross Profit
$ 9.57M$ 9.61M$ 16.53M$ 16.32M$ 10.94M
Operating Expenses
$ 10.21M$ 10.87M$ 12.54M$ 11.68M$ 8.54M
Depreciation and Amortization
$ 517.00K$ 306.00K$ 241.00K$ 386.00K$ 245.00K
EBITDA
$ -121.00K$ -1.75M$ 4.23M$ 5.02M$ 2.64M
Operating Income
$ -638.00K$ -1.26M$ 3.99M$ 4.64M$ 2.40M
Other Income/Expenses
$ -5.30M$ -2.33M$ -895.00K$ -279.00K$ -710.00K
Pretax Income
$ -5.94M$ -3.58M$ 3.10M$ 4.36M$ 1.69M
Net Income
$ -2.56M$ -3.82M$ 2.31M$ 3.92M$ 10.46M
Per Share Metrics
Basic EPS
$ -34.86$ -36.39$ 14.69$ 49.46$ 107.60
Diluted EPS
$ -34.86$ -36.39$ 14.69$ 49.46$ 107.60
Weighted Average Shares Outstanding
157.61K 157.61K 157.61K 79.28K 79.28K
Weighted Average Shares Outstanding (Diluted)
157.61K 157.61K 157.61K 79.28K 79.28K
Currency in USD

Capstone Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis